METHOD FOR TREATING PATIENTS UNDERGONE OPERATION ON THE OCCASION OF ICENCO-CUSHING SYNDROME

摘要

the invention u043eu0442u043du043eu0441u0438u0442u0441u00a0 to medicine, namely u043fu043eu0441u043bu0435u043eu043fu0435u0440u0430u0446u0438u043eu043du043du043eu043cu0443 treatment of patients with cushing's syndrome. the goal is to reduce the frequency of postoperative complications.before and after the operation u043fu0440u043eu0432u043eu0434u00a0u0442 u0438u043du0442u0435u0433u0440u0430u043bu044cu043du0443u044e u0440u0435u043eu0433u0440u0430u0444u0438u044e body u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442 integral toxicity coefficient (kit) and the index (udi), further counting display tel acute u043du0430u0434u043fu043eu0447u0435u0447u043du0438u043au043e - howling failure (u043fu043eu043du043d) by the formula u043fu043eu043du043d u043au0438u0442u0444 (u043au0438u0442u0434u0430 / u0443u0438u0444) u0443u0438u0434u0440 where u043au0438u0442u0444 rate integral toxicity damage, u0443u0441u043b.u0435u0434.; u0438u0442u0434u043e rate integral toxicity before surgery, rm3. ed.the actual index; u0443u0438u0444 hearts, ml / m; the hearts of u0443u0438u0434u0440 index before operation, ml / m, and of less than 1.0 u043fu043eu043du043d u043fu0440u043eu0432u043eu0434u00a0u0442 additional u0437u0430u043cu0435u0441u0442u0438u0442u0435u043bu044cu043du0443 yu hormone replacement therapy. with with